Stock comparison
HEICO
Strata Critical Medical
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HEI
HEICO
Market cap
$41.9B
Sector
Industrials
SRTA
Strata Critical Medical
Market cap
$530.41M
Sector
Industrials
Overall winner
HEICO HEI
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HEI | SRTA | Winner |
|---|---|---|---|
| Warren Buffett | 66B | 31F | HEI |
| Benjamin Graham | 88A | 33F | HEI |
| Philip Fisher | 73B | 45D | HEI |
| Peter Lynch | 80A | 74C | HEI |
| Joel Greenblatt | 51C | 27F | HEI |
| Charlie Munger | 60D | 40D | HEI |
| Terry Smith | 61D | 37D | HEI |
Side-by-side metrics
| Metric | HEI | SRTA |
|---|---|---|
| Market cap | $41.9B | $530.41M |
| P/E (TTM) | 57.3x | 8.8x |
| EV/EBIT | 42.2x | - |
| ROIC (TTM) | 10.6% | -4.92% |
| Gross margin | 40.24% | 20.52% |
| Net margin | 15.38% | 19.97% |
| Revenue CAGR 5y | 24.52% | 40.55% |
| EPS CAGR 5y | 21.91% | - |
| Debt / Equity | 0.6x | 0.0x |
| Dividend yield | 0.08% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HEI leads on
- ROIC (TTM)10.6%vs -4.92%+146%
- Dividend yield0.08%vs 0.0%+100%
- Market cap$41.9Bvs $530.41M+99%
- Gross margin40.24%vs 20.52%+49%
SRTA leads on
- EV/EBIT-vs 42.2x+196%
- Debt / Equity0.0xvs 0.6x+97%
- P/E (TTM)8.8xvs 57.3x+85%
- Revenue CAGR 5y40.55%vs 24.52%+40%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.